EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib
De Andrade, James P, Park, Jung M, Gu, Vivian W, Woodfield, George W, Kulak, Mikhail V, Lorenzen, Allison W, Wu, Vincent T, Van Dorin, Sarah E, Spanheimer, Philip M, Weigel, Ronald J
Published in Molecular cancer therapeutics (01.03.2016)
Published in Molecular cancer therapeutics (01.03.2016)
Get full text
Journal Article